| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 12 1505-1512, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
L Yu, Q Wu, CP Yang and SB Horwitz
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
The expression of mdr genes that encode P-glycoprotein, an integral membrane drug transporter, has been associated with the emergence of the multidrug resistance phenotype during treatment with cancer chemotherapeutic drugs. To understand the regulation of the mdr genes, the murine mdr1b promoter has been isolated and characterized in our laboratory. Three nuclear protein binding sites that interact with nuclear proteins present in both drug-sensitive and -resistant murine macrophage-like 1774.2 cells have been localized to the promoter. In this report, transcription factor NF-Y has been identified as binding to the Y-box sequence in site 1 and as a major factor in the regulation of the murine mdr1b promoter in the mouse adrenal cell line, Y-1, that endogenously expresses the mdr1b gene. The expression of CCAAT/enhancer binding protein beta (C/EBP beta) in Y-1 cells augmented mdr1b promoter activity and resulted in an increased level of mdr1b mRNA. The effect of C/EBP beta expression on mdr1b promoter activity was sensitive to mutations in the Y-box, suggesting that coordination of NF-Y with C/EBP beta is required for further activation of the mdr1b promoter. Our studies have indicated that NF-Y is a critical factor for the mdr1b promoter, and its coordination with other factors, such as C/EBP beta, could be an important mechanism involved in mdr1b gene expression.
This article has been cited by other articles:
![]() |
K. Matsusue, O. Gavrilova, G. Lambert, H. B. Brewer Jr., J. M. Ward, Y. Inoue, D. LeRoith, and F. J. Gonzalez Hepatic CCAAT/Enhancer Binding Protein {alpha} Mediates Induction of Lipogenesis and Regulation of Glucose Homeostasis in Leptin-Deficient Mice Mol. Endocrinol., November 1, 2004; 18(11): 2751 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Chen, S. Sale, T. Tan, R. P. Ermoian, and B. I. Sikic CCAAT/Enhancer-Binding Protein {beta} (Nuclear Factor for Interleukin 6) Transactivates the Human MDR1 Gene by Interaction with an Inverted CCAAT Box in Human Cancer Cells Mol. Pharmacol., April 1, 2004; 65(4): 906 - 916. [Abstract] [Full Text] |
||||
![]() |
H. S. Radomska, A. B. Satterthwaite, N. Taranenko, S. Narravula, D. S. Krause, and D. G. Tenen A Nuclear Factor Y (NFY) Site Positively Regulates the Human CD34 Stem Cell Gene Blood, December 1, 1999; 94(11): 3772 - 3780. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Kao, A. Tanimoto, N. Arima, Y. Sasaguri, and R. Padmanabhan Transactivation of the Human cdc2 Promoter by Adenovirus E1A. E1A INDUCES THE EXPRESSION AND ASSEMBLY OF A HETEROMERIC COMPLEX CONSISTING OF THE CCAAT BOX BINDING FACTOR, CBF/NF-Y, AND A 110-kDa DNA-BINDING PROTEIN J. Biol. Chem., August 13, 1999; 274(33): 23043 - 23051. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gomez, D. G. Perez, E. Lopez-Bayghen, and E. Orozco Transcriptional Analysis of the EhPgp1 Promoter of Entamoeba histolytica Multidrug-resistant Mutant J. Biol. Chem., March 27, 1998; 273(13): 7277 - 7284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sundseth, G. Macdonald, J. Ting, and A. C. King DNA Elements Recognizing NF-Y and Sp1 Regulate the Human Multidrug-Resistance Gene Promoter Mol. Pharmacol., June 1, 1997; 51(6): 963 - 971. [Abstract] [Full Text] |
||||
![]() |
M.-C. Mathieu, I. Lapierre, K. Brault, and M. Raymond Aromatic Hydrocarbon Receptor (AhR){middle dot}AhR Nuclear Translocator- and p53-mediated Induction of the Murine Multidrug Resistance mdr1 Gene by 3-Methylcholanthrene and Benzo(a)pyrene in Hepatoma Cells J. Biol. Chem., February 9, 2001; 276(7): 4819 - 4827. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |